Multigene tests in assessing and treating early endocrine-dependent breast cancer
10.3760/cma.j.issn.1674-6090.2018.05.016
- VernacularTitle:多基因检测对早期内分泌依赖型乳腺癌复发转移的评估及临床意义
- Author:
Shuting ZUO
1
;
Jianfen HUA
;
Liping ZHAO
;
Yan ZHANG
Author Information
1. 吉林大学第二医院乳腺外科
- Keywords:
Multigene test;
Oncotype DX;
MammaPrint;
Breast cancer;
Distant recurrence
- From:
Chinese Journal of Endocrine Surgery
2018;12(5):422-425
- CountryChina
- Language:Chinese
-
Abstract:
Detection of Oncotype DX and MammaPrint has been recommended by the American Society of Clinical 0ncology.For specific populations,such as early endocrine-dependent breast cancer,under the condition of sufficient evidence in the evidence-based medicine,we can choose genetic testing in combination with clinical pathologic factors to guide clinical treatment,which has reached the goal of micro combined with macro,more detailed division of the patients,and individualized treatment.
